Blog
Get Started
Login
Sign Up - Free
Log In
Blog Home
Blog Categories
Benchsci Updates
Benchsci Case Studies
AI in Drug Discovery
AI in Drug Discovery Podcast
About BenchSci
BenchSci Updates
BenchSci Case Studies
AI in Drug Discovery
The BenchSci Blog
sort
Artificial Intelligence in Drug Discovery
Aug 14, 2018
Naheed Kurji, CEO of Cyclica, on Building an AI Platform to Design, Screen, and Personalize Drugs
Artificial Intelligence in Drug Discovery
Aug 7, 2018
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Artificial Intelligence in Drug Discovery
Aug 7, 2018
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
BenchSci Case Studies
Jul 31, 2018
Stephanie Guerra on Antibodies for Characterizing Novel Combination Therapies for KRAS-mutant Lung Adenocarcinoma
Artificial Intelligence in Drug Discovery
Jul 30, 2018
Regina Barzilay on AI for Small Molecule Discovery and Synthesis
Artificial Intelligence in Drug Discovery
Jul 26, 2018
Tim Guilliams and David Brown, Healx, on AI for Rare Diseases
Artificial Intelligence in Drug Discovery
Jul 18, 2018
John Cassidy, CEO of Cambridge Cancer Genomics, on AI-Powered Disease Prediction for Oncology
Artificial Intelligence in Drug Discovery
Jul 10, 2018
Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research
Antibody Applications
Jun 28, 2018
Immunohistochemistry (IHC): Principles & Factors to Consider For Quality Results
Artificial Intelligence in Drug Discovery
Jun 28, 2018
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Artificial Intelligence in Drug Discovery
Jun 20, 2018
Shai Shen-Orr, Chief Scientist of CytoReason, on AI for Systems Immunology
Artificial Intelligence in Drug Discovery
Jun 11, 2018
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Never miss a blog post
Previous
Next
